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Dear members, I sincerely hope and pray that you are all 
well and keeping safe. 
The current pandemic and situation is unprecedented with 
significant challenges for us in healthcare. However, we now 
have an enormous opportunity to pull together like never 
before and set an example as to how both the public and 
private sectors can work cohesively. In my opinion, a 
sustainable healthcare system will require successful public-
private partnerships, which are fortunately now developing. 
SA Heart® wants to define the acceptable standards of 
cardiovascular (CV) care that will be provided with NHI; 
and to have a role in the development of CV governmental 
guidelines, algorithms and essential drugs. In March we were 
eagerly looking forward to a long awaited virtual meeting 
with the health department, which unfortunately was 
cancelled at the last minute because of the pandemic. We 
are trying to reschedule in order to introduce SA Heart® 
and to express our need to be included, as well as our 
willingness to work cohesively, which is crucial to ensure 
that there is adequate cardiovascular care for each and 
every one of our citizens. Dr Sajidah Khan, one of our board 
members, has rightfully suggested that one area in which 
we could make a huge and almost immediate difference, is 
the treatment of acute myocardial infarction (AMI). There 
are many peripheral state hospitals with no cardiac 
catheterisation facilities but are in close geographic prox-
imity to private hospitals. We have no doubt that partner-
ships could be negotiated between the health department 
and the large private hospital groups and cardiologists. 
Patients with AMI could be thrombolysed and then trans-
ferred the following day to private facilities for angiography 
and percutaneous intervention. The patients thereafter 
could be sent back to the state hospital. There are many 
other areas that we could influence. SA Heart® with all of 
you, includes the scientific cardiovascular leaders and we 
therefore want to ensure that we are the go to organisation 
for heart health in this country. I feel that there is much to 
strive for in this regard. I assure you that we will not stop 
until we have our voice heard on these matters.  
As you all well know, the SA Heart® board had to take the 
drastic decision to cancel our annual congress later this year. 
This step was not taken lightly but was necessary because 
of this enormous impact of the global coronavirus pan-
demic and circumstances that are beyond our control. I 
personally never would have envisaged that we would be 
forced to do this and it was with a heavy heart that I wrote 
to all concerned in the congress matters. I have always been 
hugely passionate about our meeting, which starts from 
nothing and progresses to an amazing scientific event. Thank 
you all for your support over the past 2 decades, we are 
sure that we will be able to host a magnificent congress in 
2021. I again wish to acknowledge the organising committee 
that had stepped forward with passion; the programme for 
“2020: Back to Basics” was well progressing up until recently. 
We will however remain connected on an ongoing basis 
and any further developments will be communicated to 
you all. A crisis will force us to be more innovative and how 
would you feel about a replacement virtual meeting this 
year? We are presently in discussions regarding such a pos-
sibility. Please urgently email me with your opinions. 
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Once again, I am humbled to have served as President. I am 
most grateful to the entire board, SIGS and regional 
branches. I again salute Erika Dau, who is the “heart-beat, 




We have created a portal on our website (saheart.org 
under the News icon) to disseminate important informa-
tion regarding cardiac issues related to COVID-19 disease. 
We invite you to contribute and send us your links to other 
appropriate articles and multimedia posts. 
SA Heart®’s new Memorandum of Incorporation (MOI) 
has been completed and will soon be presented to you the 
members, SIG’s and regional branches. This will ultimately 
require a special AGM to be voted on. The MOI will bring 
us into a more modern and inclusive modus operandi. 
There will be only one category of membership, and allied 
cardiac professionals will therefore have voting rights and 
representation on the board. It will also include indepen-
dent members with business and fund raising skills. We 
deem such a change necessary to ensure the bigger picture 
to achieve our mission, which is to champion sustainable 
healthcare, to lead and innovate in CV science, to educate 
and importantly influence policy. 
Please get actively involved in SA Heart®: co-opt yourself 
onto one or more of our committees; we want you involved 
and to provide for further constructive advice and input, 
which we look forward to. 
News from the PresideNt continued
The MOI 
will bring us  
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Dr Zongezile Masonwabe Makrexeni was born and bred 
in Mthatha, Eastern Cape Province. He is the second eldest 
of 5 children and a born again Christian. He is married 
to Dr CA Makrexeni, Obstetrician and Gynecologist at 
Nelson Mandela Academic Hospital. They are blessed with 
3 beautiful children. 
Dr Makrexeni matriculated at Mpindweni Senior Secondary 
School in 1999. He obtained his MBChB degree in 2005 at 
Walter Sisulu University in Mthatha. He was trained at 
Nelson Mandela Academic Hospital and at Red Cross 
Children’s Hospital for his fellowship in Paediatrics, which 
he obtained in 2013. He went for further training at Dora 
Nginza Hospital in Port Elizabeth for his Certificate in 
Paediatric Cardiology which he completed in 2017.
He concurrently completed his MMed in Paediatrics and 
Child Health in 2017 from the Walter Sisulu University.
Dr Makrexeni is currently working as the Head of Paedi-
atric Cardiology Unit in Nelson Mandela Academic Hospital 
in Mthatha and is the current Acting Academic Head of 
Paediatrics and Child health at Walter Sisulu University 
in Mthatha.
He enjoys being outdoors, travelling and sightseeing.
For the past 2 years Dr Blanche Cupido ably and enthu-
siastically fulfilled the role of editor of the SA Heart® 
Newsletter, a quarterly publication attached to the 
SA Heart® Journal. The SA Heart® Board, executive com-
mittee and production team of the Journal and Newsletter, 
and no doubt our membership, want to sincerely thank 
Dr Cupido for the hours spent to source news and infor-
mation, edit contributions to make for a good read and 
scrutinize detail.
The portfolio of editor of the SA Heart® Newsletter 
comes with the post of secretary on the current struc- 
ture of the SA Heart® Executive Committee. At the 
AGM in 2019, Dr Zongezile Masonwabe Makrexeni was 
announced as the new secretary of SA Heart®. Dr Cupido 
immediately started to make contact with the new 
secretary, acquainting him with the task and protocol and 
introducing him to the role players and groups within 
SA Heart® that normally contribute to the content of 
the newsletter. From issue 3 Dr Makrexeni will take over 
the reins.
Thank you, Blanche, for all your input, insight and con-
tribution over the years as secretary of SA Heart®, editor 
of our newsletter and other work, continuing with com-
mittee work and energy as president-elect as you passed 
on the baton to Maso.
BioGrAPhY - dr ZoNGeZiLe mAsoNwABe mAKrexeNi
Dr Zongezile Masonwabe Makrexeni,  
New SA Heart® Newsletter Editor.
Thank you, Blanche, for all your  
input, insight and contribution.
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In line with our objectives to advocate heart health for all, 
connect our members, and communicate key messages, 
WHF is advancing efforts to understand these linkages as 
part of its fight against the COVID-19 pandemic. A global 
prospective cohort study is set to start in May this year, 
led by the WHF Science Committee. The study aims to 
better “describe cardiovascular outcomes and identify 
cardiovascular risk factors associated with poor prognosis 
in patients with COVID-19.” 
As a reminder, based on the communication about the 
study that was sent to all Members, we invite you to iden-
tify and endorse at least 2 hospitals or other medical 
facilities (recruiting centres) from your respective countries. 
Each centre should recruit between 50 and 200 COVID-19 
patients, with no limit on the number of participating sites. 
In addition, no special tests are required and baseline data 
will be gathered from patients’ routine medical records, via 
a secure electronic form that goes to the coordinating 
centre, with follow-up in 30 days. WHF can provide USD 
25 per completed case report and Members and site inves-
tigators participating in the study will be actively involved 
in the ensuing publications. Pulling together a global picture 
and response draws on our strength as a membership 
organisation and we look forward to conducting this work 
together. To register interest, kindly get in touch with Lana 
Raspail, Programme Officer, lana.raspail@worldheart.org.
Less than a month ago, with the pandemic halting travel, 
and the number of cases and deaths from COVID-19 
growing, we managed to gather a large audience virtually in 
Chicago for the World Congress of Cardiology (WCC), 
28 - 30 March. With the American College of Cardiology 
(ACC), we were able to use technological platforms for 
the rich exchange and knowledge-sharing among our 
more than 200 Members from more than 100 countries. 
Thanks goes to the agility of ACC, the many societies and 
foundations that make up our membership, and the work 
by WHF President-elect, Professor Fausto Pinto. 
Reflecting on WCC, the current pandemic underscores the 
importance of strong health policies and robust care for all, 
and highlights areas in need of more research and funding. 
A t the time of writing, the world is in the grip of the COVID-19 pandemic, with countries at different stages of managing the disease. In some 
regions, the number of cases is still increasing while in 
others, the disease is either reaching a plateau or the 
disease curve is on a downward trajectory. At the same 
time, the frontlines of research are busy with a race to 
understand the virus better, to gain insights into possible 
immunity by those infected, and to develop antibody tests 
to assess levels of potential immunity within a population. 
Efforts are underway to assist patients most at risk of dying 
from the disease, which includes those suffering from 
hypertension, coronary heart disease and other underlying 
illnesses. In low-income countries, additional risk factors 
include, among others, Rheumatic Heart Disease (RHD) 
and cardiomyopathies. Since the disease outbreak, World 
Heart Federation (WHF) has been actively playing its part 
in the dissemination of information and collaboration with 
all branches and sectors committed to heart health, while 
maximising the opportunity of collective learning that the 
current pandemic presents. 
In order to update our members from low- and middle-
income countries on important facts on COVID-19 
prevention, the “World Heart Federation Briefing on Pre-
vention: Coronavirus Disease 2019 (COVID-19) in Low-
Income Countries,” was published on 9 April in “Global 
Heart,” WHF’s official journal with full open access as of 
January 2020, increasing visibility and accessibility, and 
widening readership by health practitioners and researchers. 
The briefing summarises facts on this novel coronavirus, 
its transmission and infection, signs and symptoms, pre-
ventative measures and recommendations.  
Densely populated areas where some of the poorest 
communities live are often beset by other diseases such as 
HIV, tuberculosis and malaria. This can intensify the threat 
of spread of highly infectious illnesses. Like earlier viruses 
such as SARS-CoV and MERS-CoV, COVID-19 presents 
heightened threat to patients with cardiovascular disease, 
pre-disposing them to developing severe forms of the 
infection. 
KeePiNG our PuLse oN the CoVid-19 PANdemiC
226 227
stakeholders. Only by doing this we will avert further loss 
and pain from the COVID-19 pandemic. It’s a battle we will 
win together.
Karen Sliwa
President, World Heart Federation
For SA Heart®
COVID-19 poses a threat to those with underlying health 
risks including impaired cardiovascular health. Many people, 
and a disproportionate number of them in low-income 
countries, are unaware of underlying health issues or do 
not have access to the needed care. As you know, RHD 
affects 33 million people worldwide, mainly the young and 
in poor countries; and Chagas disease, caused by a parasite, 
also affects the heart. In fact, just this month, WHF published 
a new roadmap intended to guide healthcare professionals, 
health authorities and governments in addressing Chagas 
disease by including recommendations for screening, diag-
nosis and treatment, all doable through concerted global 
action. In addressing the current pandemic, therefore, the 
direct and indirect causes of cardiac conditions as well as 
the particular threat posed by SARS-CoV-2 to these 
conditions, need to be understood, discussed, and widely 
shared. This is our mission and the mission of every society 
of cardiologists in the world. We need to work together to 
ensure a truly healthy global community in which we are all 
KeY resourCes & CoNtACts At A GLANCe
Brief Report in Global Heart journal: 
file:///C:/Users/lmhad/Downloads/Thienemann%20COVID-19%20Global%20Heart%202020(1).pdf
Preventing COVID-19 spread in poor areas, 5 March 2020, Geneva/Cape Town: 
file:///C:/Users/lmhad/Downloads/WHF-COVID-19-GUIDELINES(1).pdf
Recommendations for the CVD community in the context of the COVID-19 outbreak 13 February 2020: 
file:///C:/Users/lmhad/Downloads/Coronavirus-19-guidelines-on-prevention-and-control-(1).pdf
Visit the COVID-19 Resource Hub: 
https://www.world-heart-federation.org/covid-19-outbreak
To register interest in WHF’s global prospective cohort study:
Contact Lana Raspail, Programme Officer, lana.raspail@worldheart.org.
From the virtually held World Congress of Cardiology, co-hosted by the American College of Cardiology:
https://www.world-heart-federation.org/congress/
Stay informed: 
See updates by the World Health Organization







The annual CASSA symposia were held over 2 successive 
weekends in Cape Town on 29 February and in Johannesburg 
on 7 March.  These symposia have become a regular event 
on the CASSA calendar for the past 5 years with the aim 
to provide clinical updates in the diagnosis and treatment of 
cardiac arrhythmias. This year, CASSA hosted 2 dynamic 
international electrophysiologists from the United Kingdom: 
Prof Sabine Ernst (from the Royal Brompton Hospital) and 
Dr Neil Sulke (Eastbourne Hospital). Prof Ernst spoke on 
the approach to the management of patients with adult 
congenital heart disease and cardiac arrhythmias.  She is an 
expert in the field of complex arrhythmia ablation in the 
setting of congenital heart disease and spoke on the role of 
catheter ablation in the treatment of these complex 
arrhythmias.  Dr Neil Sulke gave an update on the manage-
ment of patients with syncope and ventricular tachycardia 
storm and spoke on the role of implantable loop recorders 
in the follow-up of patients with atrial fibrillation. These 
talks were supported by an excellent local faculty of 
electrophysiologists.
AfriCAN heArt rhYthm 
AssoCiAtioN
The 1st meeting of the African Heart Rhythm Association 
(AFHRA) was held in Nairobi, Kenya in January 2020.  This 
was the largest arrhythmia conference ever held in Africa. 
CASSA members (Dr Andrew Thornton, Dr Brian Vezi 
and myself) were invited faculty. AFHRA was formed in 
November 2019 by the arrhythmia task force of the Pan 
African Society of Cardiology (PASCAR).  CASSA has 
established strong links with the association together with 
other national arrhythmia societies. Dr Brian Vezi was 
elected to be a regional representative for South Africa and 
I will serve as regional representative for the Asia/Pacific 
region. The aim of this association is to:
 ■  Detect, prevent and treat cardiac arrhythmias in Africa 
 ■  Educate and train African healthcare professionals on 
the management of arrhythmogenic disorders and their 
outcomes 
 ■  Educate the public to recognise and prevent risk factors 
for cardiac arrhythmia outcomes and  
 ■   Facilitate the research of cardiac arrhythmias and 
conduction disturbances as well as in sport cardiology.
Ashley Chin
CArdiAC ArrhYthmiA soCietY 
of southerN AfriCA
Delegates attending the first African Heart Rhythm Association (AFHRA) meeting in Nairobi, Kenya in January 2020.
These 
symposia have 






to public sector practitioners and will extend this 
collaboration further in 2020. Martin Mpe is also involved 
with processes that will see the Essential Drug List (EDL) 
updated to include more recently developed molecules 
(and combinations) such as sacubitril/valsartan.
hefssA CArdioLoGY uPdAte for 
NoN-CArdioLoGist 2019 Pre-
CoNGress worKshoP
The Workshop was well attended by 172 delegates from 
across Gauteng and surrounding regions. We hope to 
expand on this in 2020. The 2020 programme conveners 
are Dr Nqoba Tsabedze and Prof Eric Klug. A survey was 
distributed to the Gauteng and surrounding GPs to indicate 
a preferred selection of topics that will be most relevant 
to their daily practice and clinical needs, these will be 
catered for in the 2020 programme.
sA heArt® CoNGress 2019 
sPoNsorshiP
HeFSSA raised funding and could sponsor 6 delegates to 
attend SA Heart® 2019 and hope to expand on this for 
the 2020 Congress.
The 1st HeFSSA Device and Treatment Expert Meeting is 
provisionally planned for end of November 2020 or early 
2021. More details to follow.
Dr Martin Mpe
I t is during these unprecedented times that our dedi-cation towards healthcare and our patients are at the forefront. I am mindful of the great sacrifices we make 
every day, demonstrating professional acumen, personal 
courage and ethics in our fight against the pandemic. 
Thank you to each healthcare worker and doctor at the 
forefront, and each practice limiting patients and appoint-
ments to the essential.
hefssA exCo
Martin Mpe (President), Jens Hitzeroth (Vice-President), 
Eric Klug (Ex-Officio President), Darryl Smith (Treasurer) 
and Nash Ranjith (Secretary), Karen Sliwa, Tony Lachman, 
Makoali Makotoko, Nqoba Tsabedze, Ntobeko Ntusi and 
Mpiko Ntsekhe. I would like to thank Dr Len Steingo for 
his many years of faithful service to HeFSSA and wish him 
all the best.
hefssA heArt fAiLure  
GuideLiNe 2019
HeFSSA HF Guideline (based on ESC HF 2016 with sub-
stantial Africanisation) has been submitted to SAMJ and 
SAHJ end January 2020 for publication. Dr Jens Hitzeroth 
led the review with substantial contributions from the 
HeFSSA Executive (as clinical and research experts).
hefssA GP eduCAtioNAL 
ProGrAmme 
HeFSSA GP Educational Programme remains a cornerstone 
of annual educational initiative: The 10th edition in 2019 
were well attended and received overwhelmingly positive 
feedback from attendees and industry with regards to the 
topics, speakers and quality of clinical case presentations. 
We had 20 meetings for 2019 (vs. 11 in 2018), with a 
record attendance of almost 1 000 delegates (vs. 426 in 
2018). We intend to continue with the HeFSSA GP lecture 
series for 2020 and will communicate topics and dates as 
soon as we have a better idea as to the full impact of 
COVID-19 on the educational year.
hefssA offiCe
HeFSSA Office also now actively engage with Department 
of Health and the Provincial Non-Communicable coordi-
nators to ensure distribution of HF Workshop invitations 










The SASCI Executive Committee is supported by several 
professionals that actively engage on SASCI matters daily. 
These are: Dr Tom Mabin, who as the founding President of 
SASCI in 2003, needs little introduction as one of the 
pioneers of interventional cardiology in South Africa. Tom 
recently semi-retired from clinical practice and is making 
time available to SASCI on various areas pertaining to 
Private Practice (incl but not exclusively CPT coding, 
Funder engagement and clinical guidance). SASCI is privi-
leged to align Tom with Karen van der Westhuizen, a 
coding expert who is currently completing a CPT cardi-
ology crosswalk and preparing the long-awaited next 
edition of the SASCI Coding Manual. SASCI is grateful to 
have secure the services of a well-respected Medical Law 
Firm, Elsabe Klinck and Associates (EKA), who continue to 
guide SASCI on submissions and legal matter through 
Ebbie Iheanyi. Few of our activities would be possible with-
out the help of George Nel and his Medsoc team: Wihan 
Scholtz (Fellows Programmes, Visiting Professors, pro-
gramme development, faculty engagement and educational 
grant management), Joh-Ann Nice (ISCAP executive, fund 
raising for the national educational lecture series, pro-
gramme development and organising of educational 
events),  Duard Smit (RSVP and issuing of CPD certificates 
as well as e-communication) and new team member Vuyi 
Khumalo who comes from the Foundation for Professional 
Development (FPD) and will be responsible for project 
support.
eduCAtioNAL iNitiAtiVes 
Educational initiatives continue to be a cornerstone activity 
for the society.  Highlights of the educational initiatives since 
the last report in October 2019.
sAsCi At sA heArt® CoNGress & 
AfriCAPCr 2019
AfricaPCR Course remains our seminal annual educational 
event receiving substantial Exco time and effort to opti-
mise the learning.  Forty two Cardiologists (including 22 
Fellows) that applied for a grant were sponsored to attend 
the SA Heart®/AfricaPCR congress 2019 (please see full 
list on SASCI website). 
A t the time of this writing, we are in the early phase of the COVID-19 epidemic and the lock-down seems to have stabilised the situation for 
now. This has however had a significant impact on our ability 
to manage our chronic stable patients as well as a financial 
impact of many members. The next few months will be 
challenging and apart from our recent activities listed below, 
we will endeavour to move forward and find innovative 
ways to add value to our members’ practices.
sAsCi exeCutiVe Committee 
A new SASCI Executive Committee was elected early in 
November 2019 at the SASCI Annual General Meeting 
2019. Hellmuth Weich was elected as President (term 
ending AGM 2021) with Jens Hitzeroth and Farai Dube 
nominated and accepted as new members of the Exco. 
Hellmuth Weich closed the AGM with a special thank you 
to Dave Kettles for his incredible service the past number 
of years and expressed his commitment to lead the society 
with support from the very capable executive committee. 
Prof Farrel Hellig was also acknowledged for his many years 
of faithful service to SASCI in various roles. He is formally 
stepping down from active executive committee duties and 
we wish him all the best. 
During the first Executive Committee meeting to follow 
the AGM, Dr Sajidah Khan was proposed and elected as 
Vice-President. We appreciate her continued contribution 
to SASCI and our interventional community for the fore-
seeable future. Both Cobus Badenhorst (Treasurer) and 
Graham Cassel (Secretary) retained their respective areas 
of responsibility with Ahmed Vachiat taking on the portfolio 
of STEMI SA that will feature more prominently in SASCI 
and the Executive.     
sAsCi exCo
Hellmuth Weich (President), Sajidah Khan (Vice-President), 
Cobus Badenhorst (Treasurer), Graham Cassel (Secretary), 
Mpiko Ntsekhe, Makoali Makotoko, Ahmed Vachiat, Chris 
Zambakides, Jean Vorster (PPC), Gavin Angel, Shaheen 
Pandie, JP Theron, Jens Hitzeroth, Farai Dube and Waheeda 
Howell (ISCAP).
sAsCi – sAsCi PPC – stemi sA ANd isCAP 2020 News
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Durban with robust discussions and debate focussing on 
Complex PCI and CTO. This proctorship programme was 
made possible by an unconditional educational grant from 
Medtronic. 
sAsCi VisitiNG Professor 
ProGrAmme 2020 
We welcomed Prof Greg Barsness from the Mayo Clinic, 
Rochester, USA who travelled to South Africa as the 
Visiting Professor for 2020. Prof Barsness taught and 
proctored at the various Medical Schools in SA from 7 
February - 22 March 2020. He was well received in Cape 
Town, Durban and Pretoria but his tenure had to be cut 
short due to the COVID-19 worldwide pandemic. The 
SA Heart® Branch and SASCI Evening Lectures that also 
expose Cardiologists and Allieds in private sector to our 
VP took place in Cape Town and Durban. The evening 
lecture “State of the Art STEMI Care: Strategies for Suc-
cess” was video recorded and will be made available via 
the web with CPD accredited Questionnaire. We hope 
Prof Barsness can return to continue his sterling work at 
some stage in the future. Please see Prof Barsness own 
report back separately.  
Prof David Holmes is confirmed to return to South Africa 
in early 2021 as Visiting Professor. The multiyear support 
received from Medtronic and Pharma Dynamics makes this 
programme a reality. 
BostoN rC frAser iNterNAtioNAL 
feLLowshiP  
SASCI sends a Fellow to Prof Simon Redwood at Guy’s 
and St Thomas’ Hospital, London for up to one month, 
annually. The incumbents are Dr George Harris (UFS) 
under the 2019 programme and Dr Karim Hassan (US) for 
2020. We hope that both candidates will be able to travel 
following COVID-19. 
medtroNiC feLLows Course At 
CoLumBiA uNiVersitY New YorK 
CitY feB 2020
Darrin Naidoo (Inkosi Albert Luthuli Central Hospital), 
Mazwi Mabika (Charlotte Maxeke Johannesburg Academic 
Hospital) and Bradley Brits (Steve Biko Academic Hospital) 
had the opportunity to travel to New York to attend this 
Fellows Course.
soCietY for CArdioVAsCuLAr 
ANGioGrAPhY ANd iNterVeNtioNs 
fALL feLLows Course 2019
With support from SCAI and Boston Scientific, SASCI 
supported 5 South African fellows to attend the SCAI 
Fall Fellows course in December 2019. The 5 recipients 
were Ndikondisene Tshiovhe (WITS), Ashandren Naicker 
(UKZN), Zimasa Jama (CT), James Fortein (UFS) and Jerry 
Chen (UP). They attended the SCAI Interventional 
Cardiology Fellows Course in Las Vegas from 6 - 10 
December 2019.  
SASCI is looking forward to once again support Fellows to 
attend the SCAI Fall Fellows Course from 4 - 8 December 
2020 in Miami, Florida. 
sAsCi VertiCe exPert ProGrAmme
Prof Tony Gershlick, Professor of Interventional Cardiology, 
University of Leicester visited various cath labs in 
Johannesburg, Pretoria and Cape Town from 3 - 15 
November 2019, spreading his time across public and 
private hospitals. Prof Gershlick proctored Cardiologists 
on complex PCI, with specific focus on Bifurcations. 
During his visit he presented at the SA Heart® Pretoria 
and Johannesburg Branch meetings with 51 and 31 
attendees respectively and a roundtable discussion dinner 
was also arranged in Cape Town. 
This proctorship programme was made possible by an 
unconditional educational grant from Vertice Healthcare 
and has been confirmed to continue in 2020, focusing on 
the Western Cape and KwaZulu-Natal Regions where we 
hope to welcome Prof Gershlick back for a second visit. 
sAsCi medtroNiC ProCtorshiP 
ProGrAmme 
Dr William Lombardi, Clinical Professor of Medicine in the 
Division of Cardiology at the University of Washington 
Medical Center visited multiple cath labs in Cape Town and 
Durban from 13 - 17 January 2020. Dr Lombardi proc-
tored Cardiologists on complex PCI and CTO cases and 
was acclaimed as an exceptional teacher throughout. He 
also included the allied practitioners in his teaching with a 
strong focus on maintaining a holistic view of the cath lab. 
A roundtable discussion dinner was also arranged in 





Dr Ahmed Vachiat has recently been appointed as the new 
chair of STEMI SA. We wish to thank Dr Adriaan Snyders 
for his commitment and hard work toward the project 
from the start and SASCI will rely on his continued input 
and contribution. If any colleagues wish to be involved in 
the data capturing side of the project, Dr Kettles, who is 
leading the data collection of the project, eagerly awaits 
your declaration of interest. Educational Workshops have 
and will continue to be arranged to assist those who wish 
to strengthen STEMI care in their region.  The STEMI SA 
”Acute Coronary Syndrome Educational Slide Set” is 
available on the SASCI website and will allow self-study 
with CPD accredited questionnaires available during 2020 
http://www.sasci.co.za/content/page/stemi-sa
sAsCi PPC, LeGAL ANd reGuLAtorY 
eNViroNmeNt
SASCI PPC under the leadership of Jean Vorster (Chair) 
with support from Tom Mabin (consultant) and Karen van 
der Westhuizen (coding expert) has been extremely active 
during 2019 and the first months of 2020. The committee 
includes David Jankelow, Andrew Thornton, Dave Kettles, 
Gavin Angel, Graham Cassel, George Nel, Wihan Scholtz, 
Ebbie Iheanyi and Elsabe Klinck with an open invitation to 
others to contribute. 
PPC members have been involved in various Funder 
Engagements.  We contributed to revision of the Discovery 
Health CAD Programme for 2020 – SASCI advised 
Discovery Health on various aspects of the programme, 
especially the inclusion criteria and ICD-10 codes to 
be used.  Coding queries can be directed to SASCI 
(sasci@sasci.co.za).  SASCI PPC with Dr David Jankelow 
secured an “Urgent Errata communication from SAMA 
that was sent to all healthcare stakeholders with regards to 
MDCM items 1276 and 1252”.  All members are encour-
aged to engage with SASCI and/or seek legal representa-
tion (such as Elsabe Klinck Associates), before engaging with 
the schemes on queries or especially audits. 
sAsCi CodiNG hANdBooK 
Karen van der Westhuizen is updating the SASCI Coding 
Handbook (to be issued mid 2020). SASCI publishes this 
Guideline to guide professionals, funders and other stake-
holders as to the appropriate coding of professional acts. 
This Coding Guideline is based on a scientific and pro-
fessional analysis of the various professional acts, which duly 
registered professionals are by law entitled to undertake in 
terms of their registration under the Health Professions 
Act, 1974, and the Ethical Rules, and which acts are trans-
lated into codes that serves as a “short-hand” description 
of such acts. 
Nhi BiLL 
NHI Bill has been tabled in Parliament and SASCI sub-
mitted and extensive opinion at the end of November. 
ComPetitioN CommissioN heALth 
mArKet iNquirY rePort 
Competition Commission Health Market Inquiry Report 
was issued end 2019. The report highlighted that the 
recommendations from the HMI should be implemented 
before NHI is implemented. It HMI Report also advises 
Government that collective bargaining (of fees) which was 
previously not allowed by the competitions Act, should 
be allowed. This is however only a recommendation at 
this stage. 
mediheLP tAVi CAse
Positive CMS ruling that the scheme should reimburse 
TAVI up to the cost of open-heart surgery. This ruling 
contains actual costs analysis which reflect that TAVI is less 
costly than open-heart surgery but is based on a limited 
number of cases. Medihelp has lodged an appeal (in 
December 2019) and we await the appeal date but will 
prepare our arguments in meantime.  
seCtioN 21 mediCiNes 
Members should ensure the suppliers of the Section 21 
medicines are correctly registered before engaging with 
them. SAPHRA audits are taking place. 
NoN-CommuNiCABLe diseAses 
NDOH’s new draft policy on Non-Communicable Diseases 
as well as Primary Healthcare Essential Medicine List was 
published and SASCI, with assistance from Tom Mabin and 
EKA, has submitted substantial comments. 
sAsCi – sAsCi PPC – stemi sA ANd isCAP 2020 News continued        
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The next submission due is at the end of June 2020 and 
focusses on the PUBLIC PROCUREMENT BILL that will 
govern procurement that underpins NHC. 
iNterVeNtioNAL soCietY of CAth 
LAB ALLied ProfessioNALs:   
News APriL 2020
Unfortunately, the COVID-19 restrictions have curtailed 
our plans for the mid-year educational lecture series, but 
we are in discussion with our sponsors to continue with 
lectures as soon as possible and deemed safe to do so.  We 
are disappointed to lose momentum but protecting the 
health of our members and that of the public is a respon-
sible recourse and support efforts to stem the spread of 
the Coronavirus.
In the meantime, ISCAP are planning to host an Educa-
tional Webinar, discussing “Cathlab Environment – During 
and Post COVID-19”. The programme launched at the 
end of April.
The following activities took place since our last report:
sA heart® & AfricaPCr Grants 2019
AfricaPCR Course and SA Heart® Congress remains an 
important annual educational event to optimise member 
learning. ISCAP could provide 24 Allied Professionals with 
sponsorship to attend the SA Heart®/AfricaPCR congress. 
The Office is continuously approaching industry for educa-
tional grants to support the allied professionals to attend 
the upcoming joint SA Heart® & AfricaPCR Congress. 
isCAP Catheterisation manual
Dianne Kerrigan and Gill Longano have worked tirelessly 
to update the ISCAP Cath Lab Manual online version, as 
well as the development of additional chapters.  The first 4 
are currently available and CPD Accredited:
Module 1: The Historical Developments of Coronary 
Angiography, Cardiac Anatomy and Physiology, Basic ECG 
Interpretation and Coronary Pathology
Module 2: The Roles and Responsibilities of the Cath Lab 
Team, Indications and Contraindications for Coronary 
Angiography, Basic Concepts in Cardiac Catheterisation 
and Asepsis in the Cardiac Catheterisation Laboratory
Module 3: Radiation and Contrast Agents, Vascular Access, 
Percutaneous Coronary Intervention (PCI) & Coronary 
Artery Stents and Right Heart Studies
Module 4: High Risk Patients, Minor and Major Compli-
cations, Cardiomyopathies and Pharmacology
The above Modules are available on the Boston Educare 
Platform and are each linked to a CPD Questionnaire with 
accreditation of 3 Clinical CPD Points each. To view the 
Modules and complete the CPD Questionnaires visit 
sasci.co.za.
Thank you to Boston Scientific for their help in developing 
the ISCAP Manual which will hopefully reach more allieds 
through an online platform.
isCAP educational workshops 2020
ISCAP is focussed on ongoing training for all Cath Lab 
Allieds including nurses, radiographers and technologists 
We wish  
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across South Africa. We had a roaring start to 2020, with 
Lecture Series’ starting in January! ISCAP would like to 
thank you for supporting these lecture meetings and thus 
contributing to the excellence we believe every Cathlab 
should maintain, as well as conveying knowledge to our 
fellow colleagues.
isCAP riverdene Breakfast symposium
On 25 January, we hosted a CPD accredited Breakfast 
Symposium in Durban on the “Practical Application of 
Contrast in the Cath Lab”. The allieds had the privilege of 
listening to Claudia Giger, practice manager and fulltime 
radiographer at XRad Vision private practice, who was 
well received by all. We had a wonderful turnout of 57 
Attendees at this workshop. A special thank you to the 
Riverdene team, who made this workshop possible.
isCAP Biotronik siemens takeda series 2020
The Lecture Series consisted of the following topics:
 ■ Closed Loop Stimulation 
 ■ Fabry Disease and the Cardiac Patient
 ■ Radiation Protection
The lectures were CPD Accredited for 3 Standard CEU 
through the University of Pretoria and well attended. 
8 February:  Cape Town 95 Allieds in attendance 
29 February:  Midrand 63 Allieds in attendance
29 February:  Durban 56 Allieds in attendance
7 March:  Bloemfontein 25 Allieds in attendance
21 March:  Port Elizabeth 28 Allieds in attendance
During this series Drs Moses, Pecoraro, Tsabedze, Govender, 
Khan, Adamu and Butau presented on Closed Loop and/or 
Fabry Disease. Radiographers Ernest Horsley, Kerry Moir, 
Selvan Govindsamy and Sr Kerri Meyer presented on 
Radiation protection in the cathlab. All speakers were well 
received, and the topics noted as very informative.  The 
combination and diversity of these three topics was a huge 
success and a great start to the 2020 programme.
Thank you to Biotronik, Siemens and Takeda for sponsoring 
this lecture series. Their respective field force made this 
series possible, ensuring that 267 allied professionals were 
given the opportunity to engage on these topics, furthering 
their education.
We thank our Corporate Support for their 
continued and unwavering support of ongoing 
education in the Cath Lab. If you require more 
information regarding the topics, etc. for the above 
workshops, kindly contact the ISCAP Office at 
joh-ann.nice@medsoc.co.za
Dr Hellmuth Weich
sAsCi – sAsCi PPC – stemi sA ANd isCAP 2020 News continued        
CoVid-19 News
Please consult the SA Heart® webpage regularly where we 
are posting COVID-19, mostly locally relevant, updates.  
Please also contribute should you have information of 
importance to other members and CVD health care workers. 
You can email info@saheart.org with your contribution.
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Prof Barsness with the Cathlab team at Groote 
Schuur Hospital, Cape Town. 
Prof Barsness with the Cathlab team at Steve Biko 
Academic Hospital, Pretoria
I t is with fond memories that I submit this report on my recent experience as the SASCI Visiting Professor. Participating in the 2020 SASCI VPP has truly been one 
of the highlights of my career. The opportunity to integrate 
and practice alongside the South African interventional 
cardiology community was both professionally rewarding 
and personally fulfilling. I feel that I have made lasting friend-
ships among the many eager and talented faculty while 
hopefully opening avenues for trainees to grow and chal-
lenge themselves into the future. I would without question 
recommend the programme to my US colleagues, and 
better yet, would welcome the opportunity to return again 
myself some day! 
Many aspects of the programme worked well and con-
tributed to the overall exceptional experience. In general, I 
was greeted with a warm reception by faculty and found 
universal enthusiasm in the trainees with whom I was 
fortunate to meet and interact. My South African colleagues 
were warm, welcoming, and eager to share their know-
ledge and experience. There was a general openness to 
my presence and willingness to consider novel care 
opportunities within the constraints of the available 
resources – which were, in fact, less limiting than I had 
initially anticipated when planning for the visit. Starting the 
experience in Cape Town was beneficial in this regard, as 
human and procedural resources were relatively more 
plentiful and there was a high level of enthusiasm, pro- 
viding an early benchmark of the potential limitations 
and opportunities for future experiences at the other 
institutions.
Many centres attempted to fully integrate me into the 
hospital programme, including daily teaching, rounding and 
interventional procedural activities, a combination of acti-
vities that proved most effective. I enjoyed experiencing 
the routine while familiarising myself with the overall flow 
of the various practices. This gave an appreciation of the 
scope of practice and allowed me to tailor my focus to 
meet the specific needs of the sites. I was impressed by the 
complexity and challenge of the patients, who were among 
the most compliant I have ever cared for anywhere in the 
world, and witnessing the focus and dedication of the care 
teams was phenomenal.
Several specific programmatic elements facilitated a good 
experience. Participation on hospital rounds, including 
critical care rounds, was very helpful in creating an inclusive 
atmosphere and permitted greater continuity and famil-
iarity for me to optimise teaching opportunities with the 
trainees. I found this of particular value given the extra-
ordinary teaching that occurs regularly on rounds at these 
institutions, and I took away valuable personal lessons that 
I will be certain to add to my teaching armamentarium 
when back home. I would suggest that this could be 
extended to more routine visits with pre-procedural and 
follow-up of post-procedural patients, which I think would 
even further enhance the experience, although admittedly, 
time constraints limit this opportunity to some extent. 
Continued on page 236




From a procedural perspective, the experience at several 
centres was helpful in identifying best opportunities for 
teaching and practice. At centres with higher case volumes, 
scheduling a combination of pre-selected, complex inter-
ventions along with unselected but high-impact proce-
dures seemed to optimise the overall experience with 
faculty and trainees. The ability to work side-by-side on a 
spectrum of cases permitted improved collegiality, conti-
nuity of teaching, and the ability to build on concepts with 
the trainees to reinforce training already being done by 
local colleagues. In addition, exposure to the entirety of 
cases, from patient selection to access to completion, while 
requiring ample time and some interruption of the usual 
care flow, provided the best experience for me and seemed 
to promote confidence and enhanced learning for the 
trainees. 
Similarly, the experience was enhanced at centres that 
permitted greater trainee exposure to case selection, pro-
cedural planning and didactic conferences during my 
participation. Going through procedural planning and 
carrying this forward with focused didactic sessions and 
patient follow-up proved to be well-received and enhanced 
interaction and educational opportunities.  Tying all of this 
together, daily lectures, especially when pre-scheduled, pro-
vided exceptional opportunity for interaction and engage-
ment with faculty and fellows, especially when there was 
some flexibility to modify the talks or add additional ses-
sions based on previous daily experience. 
Importantly, some centres permitted additional time for 
faculty interaction, sharing best practices in clinical care, 
research and education. Case selection discussions, research 
review and focused small-group meetings of faculty with 
special interests added to the camaraderie and facilitated 
the over-all educational atmosphere. I think that these 
interactions strengthened the experience for all involved, 
including enhancing the educational atmosphere for 
trainees. In addition, there is potential for encouraging 
research collaboration amongst a team of interested faculty 
and trainees, potentially expanding to ongoing national or 
even (ideally) international collaboration over time.
Some aspects of the programme prevented an optimal 
experience for me and the cardiology teams. To some 
extent, the latter portion of my visit was overshadowed by 
the mounting COVID crisis, and this limited my participa-
tion in the general cardiovascular programme in a sub-
stantial way at these centres. In addition, institutional and 
human resource limitations had some negative effect on 
the visit, with centres stretched thin by high volumes and 
limited personnel finding it understandably difficult to 
deploy necessary time and resources. Unfortunately, limi-
tations beyond local control, such as load shedding, had a 
negative impact on planned activities. Again, when anti-
cipated, contingency planning for alternate activities at 
affected centres was necessary and often successful to 
mitigate the negative effects of these limitations.
sAsCi VisitiNG Professor ProGrAmme 2020 continued                              
Prof Barsness in the Cathlab at Inkosi Albert Luthuli 
Central Hospital, Durban.
Prof Barsness with Alfonso Pecoraro and Jane Moses 
at Tygerberg Hospital, Cape Town
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Regardless of resource availability, the best experiences 
were at centres that had done the most pre-visit pre-
paration. Limited preparation for the visit hindered a rapid 
startup, and given the limited timeframe at each center, 
even a small delay in the ability to “jump in” had negative 
repercussions on teaching and engaging trainees. To some 
extent, this was also reflected in a smaller procedural 
patient volume and limited the ability to provide educational 
continuity. This is unfortunate given the large underlying 
volume of patients amenable and suitable for discussion, 
intervention and teaching. Greater institutional pre-visit 
consideration to goals and expectations for the experience 
is a vitally important aspect of a successful visit.
A fundamental, but perhaps irremediable limitation was 
the quick transition between sites, including short stays at 
private labs. A minimum of 7 - 10 days/site seems optimal, 
with longer stays at larger sites. Shorter stays, especially if 
limited by less pre-visit preparation, proved quite limiting 
for my comfort and teaching efficacy, as learning the local 
system and gaining the familiarity and trust of local pro-
viders (and vice versa) is essential for an effective visit. 
The private lab visits could be improved if there was some 
way to extend time commitments at these centres or 
allow a means of introduction and expectation-setting 
prior to what amounts to a single 6 -  8 hour exposure.
A number of opportunities exist for further programmatic 
enhancement. These include more dedicated time for 
unstructured interaction with trainees, which has significant 
potential to enhance subsequent focused learning oppor-
tunities. Indeed, more direct trainee exposure, both during 
procedures and in an informal educational exchange setting, 
including wide-ranging discussions related to research, 
clinical care and career planning would be of particular 
interest and benefit. Similarly, formalising an international 
trainee exchange programme would be mutually beneficial 
if logistics could be managed.
Opportunities for direct faculty interaction and collabora-
tion were spotty but very enjoyable and potentially 
productive. Enhanced opportunities for focused faculty 
interaction would be welcome to increase the likelihood of 
successful collaboration among a group of busy clinicians. 
Pre-visit tele-meetings might facilitate such interactions, 
with pre-arranged post-visit follow-up furthering the cause. 
Given the unique disease patterns present in South Africa, 
there are multiple opportunities for local and international 
research collaboration. While there were many research-
related discussions during my visit, a formal mechanism for 
research collaboration would increase the likelihood of 
seeing projects move forward from an initial conceptual 
phase. This should be an emphasis for future programmes 
and could be further enhanced by pre-visit consultation 
and discussion to set a framework for potential high-impact 
and desirable projects. In this way, baseline data collection 
or research could precede the visit and allow actual 
progress during the visit. Involvement of a team of motivated 
faculty and trainees would be ideal.
From an administrative standpoint, the overall quality of 
the programme was excellent. Accommodations were 
very comfortable and there was very generous local 
support for transportation, activities, social programming 
and clinical support, which was instrumental in creating a 
successful and memorable visit. I was impressed by the 
uniform availability of subspecialised equipment at most 
sites, an element of the programme that was well-conceived. 
Greater programmatic influence over assuring visit pre-
paration at each site and assisting with local logistics such 
as internet access would be helpful. 
Although my stay was unfortunately cut short due to the 
COVID outbreak, I found the experience to be extremely 
valuable and I am grateful for the opportunity to have 
participated as a SASCI VP. I can only hope that my 
contribution to the programme provided even a fraction 
of the tremendous benefit that I received by being a 
member of the South African interventional cardiology 
community.
Wishing you all good health and hope to see you again 
soon.




T he Lipid and Atherosclerosis Society of Southern Africa (LASSA) remains a small group that focuses on metabolic errors in lipid and lipoprotein meta-
bolism which impart a high risk of severe illness. However, 
the common dyslipidaemias which are a significant contri-
butor to atherosclerosis risk at a population level are not 
ignored. Atherosclerotic cardiovascular disease remains 
the main cause of morbidity and mortality in developed 
countries and is becoming increasingly relevant in devel-
oping countries.
The LASSA committee, as well as the LASSA membership, 
is concerned about the difficulties in developing the 
emerging discipline of lipidology in South Africa. The waning 
support at teaching hospitals for dedicated clinics and a 
special laboratory, which could serve both public and 
private sector patients with severe disorders, has resulted 
in less research and has failed to attract younger colleagues 
into the discipline. There is serious concern about our 
ability to translate all of the improvements in diagnosis and 
management of severe dyslipidaemias in South Africa as 
well as in the whole continent of Africa.
It is increasingly difficult for LASSA to attract attendance 
at meetings in general and opportunities for a career in 
lipidology are, for practical purposes, non-existent. Joining 
sessions with the SA Heart® as well as the Society for 
Endocrinology and Metabolism and Diabetes of South 
Africa (SEMDSA) remain important ways to enhance the 
insight into and the management of dyslipidaemias.
The increasing pressure on administration and docu-
mentation in all organisations meant that LASSA revised its 
constitution recently to allow function under the current 
circumstances. The updated constitution was circulated to 
the membership in December but there was a poor 
response in comments from the members.
The LASSA committee recently received several docu-
ments for comment.  The documents were reviewed during 
the less busy holiday period at the end of last year and the 
beginning of 2020. It seemed that the South African 
Dyslipidaemia Guidelines, developed in collaboration with 
SA Heart,® had not influenced the planning much. In 
addition to supplying the newest version of the Guidelines, 
LASSA also commented on the Department of Health 
the LiPid ANd AtherosCLerosis soCietY of  
southerN AfriCA (LAssA) rePort BACK
strategic plan for non-communicable diseases and the 
Council for Medical Schemes revision of management 
guidelines for primary health care. LASSA also commented 
on the South African Medical Association document on 
primary health care. It is not certain how well these 
revisions are being coordinated.
An analysis of the need for lipidologists in South Africa was 
included with the replies. Conservatively,  we should aim to 
train about 150 such individuals who should be deployed 
across the country in 75 centres to cater for dyslipidaemia 
management broadly. The chief need is for expertise in 
the diagnosis and management of familial hypercholes-
terolaemia (FH), as the estimate is of 250 000 heterozygous 
FH individuals in the country. There are, however, many 
other lipid disorders which need attention from the 
neonatal age to adults. The diagnosis of these disorders is 
also a dilemma as neither private nor public domain labo-
ratories provide diagnostic services beyond automated 
assays of the lipid profile.
FH is receiving much attention overseas to ensure that 
there is optimal translation of basic, epidemiologic and 
pharmacologic research to clinical patient care. LASSA was 
represented by Prof Marais at the FH Foundation meeting 
that culminated in a publication for a “global call to action”. 
(Katherine A. Wilemon,  Jasmine Patel, Carlos Aguilar-Salinas, 
et al. Reducing the Clinical and Public Health Burden of 
Familial Hypercholesterolemia. A Global Call to Action. 
JAMA Cardiology 2020 January 2nd). Personal approaches 
about this development to journalists managing health 
matters at The Sunday Times, The Argus, The Cape Times 
and Die Burger did not succeed in the newspapers 
The chief need  
is for expertise in 




important for all medical practitioners, it is especially 
important for physicians and paediatricians. It is also hoped 
that the members of panels making decisions about drug 
prescription will make use of the opportunity for updating 
themselves on the diagnosis and management of FH. 
Similarly, a course was to be presented at the University of 
the Free State but had to be cancelled owing to the 
lockdown around the COVID-19 epidemic.
LASSA anticipates playing a role in education and diagnostic 
support as well as recommendations for management in 
all spheres of dyslipidaemia. The most important aspect 
remains the diagnosis and management of FH as mono-
clonal antibodies to PCSK9 have added another powerful 
step in improving control of dyslipidaemia after statins and 
ezetimibe.
Professor Emeritus A.D. Marais
mentioning this international venture. The difficulties of 
managing severe dyslipidaemia were discussed in an edi-
torial article (Marais AD, Cardiovasc J Afr 2019;30:247-248) 
in the Cardiovascular Journal of Africa last year, along with 
the proceedings of a meeting on FH co-hosted by LASSA 
(Marais AD, et al. Cardiovasc J Afr 2019;30:261-268) and 
the successful experience with monoclonal antibody treat-
ment of FH in South Africa ( Dirk J Blom, Johannes Breedt, 
Lesley J Burgess, et al. Caradiovasc J Afr 2019;30:279-284).
LASSA, recognising the need for education in lipidology, 
successfully arranged a course at the request of Dutch 
colleagues in 2018. Good support from some of the 
pharmaceutical companies made it possible to hold a similar 
course in Cape Town in 2019. Such a course was planned 
in May 2020 but is now postponed to October 2020 owing 
to the impact of the coronavirus epidemic and local 
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The SHARE-TAVI project continues to expand, and the 
annual number of implants in South Africa is increasing 
steadily. We are excited to be able to announce that the 
TAVI registry has reached the milestone of over 1 000 
implants captured since inception! 231 TAVI were captured 
across South Africa in 2018, and 2019 saw 278 TAVIs 
captured. Together with the cases captured, the registry 
tracks patients in the funding approval process, and 200 
patients are awaiting decisions from the Funders. A further 
200 patients are followed up to 1-year, as they exited the 
TAVI programme after they were evaluated, the majority 
exiting due to declined funding or affordability issues where 
low value partial funding is offered by some Funders.
There remain several barriers to access to this technology 
for appropriately selected patients due to the prevailing 
funding landscape in South Africa. Geographically equitable 
access is being addressed with the establishment of new 
sites in less serviced provinces, however several Funders 
are resisting the establishment of additional TAVI centres, 
and patients are forced by the Funders to travel to 
Johannesburg, Durban or Cape Town for their treatment. 
Data from the SHARE-TAVI registry presented in a poster 
at the SA Heart® Congress 2019 showed that procedural 
success in the existing TAVI sites was both comparable with 
the favourable outcomes seen overseas in large registries 
and trials, and importantly in our low volume setting in 
South Africa, was independent of site volumes. This evi-
dence from the locally obtained data from the SHARE-
TAVI registry has been shared with Funders in an attempt 
to provide relevant information for their decisions in a 
South African setting, and it is hoped that by providing 
insight into the favourable outcomes seen in South Africa 
to date, that Funders will expand their support for the 
TAVI procedure. This type of liaison with Funders is con-
sidered an important part of the mission of the SHARE 
projects, which primarily aim to improve patient care, and 
facilitating access to appropriate care is regarded to be part 
of that mission. SHARE is also directed to publish the results 
from the registries, and has had several abstracts accepted 
at local and international meetings to this effect. This year 
abstracts have been submitted to EuroPCR 2020 and the 
ESC Congress 2020, and acceptance has been received for 
an abstract at EuroPCR. While the capture rate of 92% 
for database entries of TAVI in South Africa is very high and 
is impressive for a voluntarily subscribed registry, the 
importance of entry of follow-up data can not be over-
emphasised. The SHARE office will be sending out 
reminders to all sites regarding outstanding capture of 
follow up data, as this data needs to be entered before 
June, when the data will be extracted and analysed for the 
first of the manuscripts which will issue from this project.
shAre-sAffr – AfiB/fLutter reGistrY
Atrial fibrillation, with the accompanying high prevalence 
of stroke, has a distressing impact on all South African 
communities. Besides increasing costs of care to individuals, 
Funders and the State, strokes have a knock-on effect to 
the local economy as bread-winners may have to leave 
employment to care for family members who have experi-
enced the disabling effects of stroke, or bread-winners may 
have experienced stroke themselves. Literature shows that 
stroke in South Africa occurs in a younger demographic 
than the average worldwide.
Treating atrial fibrillation effectively in both high- and low-
resource South African communities can therefore have 
an economic and social influence that will be extensive. 
The incidence and treatment variations in different settings 
for atrial fibrillation in South Africa is not well known, and 
the SHARE-SAFFR registry has been developed to investi-
gate this. The registry was initiated in November 2019 at 
the SA Heart® Congress, and sites have been chosen to 
give a representation of both State and Private settings, 
across provincial boundaries, in an attempt to get a birds-
eye view of the variations relating to incidence and treat-
ment of atrial fibrillation throughout South Africa. The 
project has Ethics approval and applications have been 
submitted for additional sites to join the registry.
Cdm reGistrY
The CDM registry has been closed for enrolment, and no 
further patient enrolment is planned. Feriel Azibani from 
the Hatter Institute was tasked with producing a manuscript 
on the existing data, but as she has now taken extended 
leave, SHARE staff, with the support of Prof Sliwa will start 
with preparation of the first manuscript from this registry 
this quarter.
The SHARE projects are bearing fruit and we are planning 
to expand the number of projects in the latter half of 
the year. Four projects have been proposed but will only 
be able to proceed when the technology or pharmaceu-
tical has approval from SAHPRA. The SHARE projects 
will continue to strive to improve patient care through 
the gathering of locally relevant data that can inform 
decision making for South African conditions. Applications 
and proposals for new registries are welcomed and any 
queries can be addressed through the SHARE Project 
office with Elizabeth Schaafsma on 083 603 7700 or 
elizabeth@saheart.org.
Reporting by Elizabeth Schaafsma on behalf of Prof Mpiko 
Ntsekhe, Chair of SHARE Committee
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 sYmPosium iN durBAN feBruArY 2019
PrediCtiNG iN-hosPitAL mortALitY iN heArt fAiLure 
usiNG mAChiNe LeArNiNG
in sub Saharan Africa is predominantly non-ischaemic. The 
aim of the study is to predict all-cause in-hospital mortality 
in patients with heart failure using supervised machine 
learning algorithms.
Models predicting mortality and rehospitalisation will be 
created with data from patients admitted in the cardiology 
wards at Charlotte Maxeke Johannesburg Academic 
Hospital between January 2009 and December 2018. 
Variables that will be used as predictors are shown in 
Table 1. Both traditional statistical methods and machine 
learning algorithms such as support vector machines, 
decision trees and random forests will be used to create 
Heart failure is a growing problem in sub Saharan Africa, 
frequently manifesting as a sequel of hypertension. Despite 
improvements in the therapy used in heart failure, up to 
50% of patients with heart failure demise within 4 years 
from the time of diagnosis. Risk predictive models have 
been proposed as tools used in the risk stratification of 
patients with heart failure. None of the available risk models 
predicting mortality or rehospitalisation in patients with 
heart failure were created using data originating from 
Africa. Also, models created from data originating in the 
developed countries may not be generalisable to our 
population considering that the aetiology of heart failure 
Continued on page 242
tABLe i: demographic and clinical data that will be extracted from the database and used to build heart failure 
predictive models.
Categorical variables Continuous variables
Demographic data Gender, ethnicity Age
Co-morbidities Hypertension, diabetes mellitus, smoking, 
dyslipidemia, family history of coronary artery 
disease, human immunodeficiency virus (HIV) 
and chronic kidney disease
Clinical examination findings Lung crepitations, ascites, elevated jugular 
venous pressure, pedal oedema, displaced apex 
beat, New York Heart Association (NYHA) 
functional class
Systolic and diastolic blood pressure
Electrocardiography Rhythm, P wave, Q wave, bundle branch block, 
ST segment
Heart rate, PR interval, QT interval
Echocardiography Left ventricular internal diameter at diastole 
(LVIDd), Left ventricular internal diameter at 
systole (LVIDs), Left ventricular ejection 
fraction (LVEF) and Left atrial size
Diseased vessel on coronary angiography Left main artery, left anterior descending artery, 
right coronary artery, circumflex artery and 
diagonal artery
Laboratory results Troponin I, haemoglobin, sodium, potassium, 
urea, creatinine, International Normalised Ratio 
(INR), total cholesterol, low-density lipoprotein 
(LDL), high-density lipoprotein (HDL), glucose, 
glycated haemoglobin (HBA1c) and pro-brain 
natriuretic peptide (proBNP)
Oral medication Aspirin, beta-blockers, furosemide, angiotensin 
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predictive models (Figure 1). The model with the best 
accuracy scores will then be used to estimate risk scores.
ProGress uPdAte
In 2017, I completed my masters’ degree and passed with 
distinction. The paper arising from my masters was sub-
sequently published in the Cardiovascular Journal of Africa. 
I am now in the phase of merging patient data in the 
Microsoft Structured Query Language (SQL) database. 
The project is supervised by Professor Hopewell Ntsinjana, 
the head of paediatric surgery at Nelson Mandela Children’s 
Hospital and Professor Turgay Celik, a professor in the 
school of Computer Science and Applied Mathematics at 
the University of the Witwatersrand.
hiGhLiGhts
As a full-time PhD student, I have the privilege of:
 ■  Learning clinical cardiovascular medicine: I have had an 
opportunity to attend weekly academic meetings, ECG 
tutorials as well as journal club meetings in the Division 
of Cardiology.  This has exposed me to cardiovascular 
clinical medicine as well as cutting edge research in the 
field.  I also had an opportunity to attend symposiums 
and conferences dedicated to the management of 
cardiovascular diseases. 
 ■  Being an activist for cardiovascular diseases: I managed 
to organise and implement the World Heart Day 
Event, where we organised a 5km and 8km run as well 
as offered free screening services for cardiovascular 
diseases in collaboration with the Heart and Stroke 
Foundation SA.
 ■  Receiving wards -  I am a recipient of:
-  The South African Heart Association Research award 
-   The Professor Bongani Mayosi Netcare Scholarship 
award
-   The Carnegie Corporation of New York Research 
award
-  The Discovery Academic Foundation award 
Dr Dineo Mpanya
University of the Witwatersrand































fiGure 1: Algorithm for creating predictive models using data from patients with heart failure.
Export patient data from SQL 
Data cleaning 
LVEF ≥50% LVEF >50%
Build model
Select patients with heart 




trAVeL sChoLArshiPs of the 
south AfriCAN heArt AssoCiAtioN
Applications for the SA Hear t® Travel Scholarship for the third term in 2020 are invited to reach the SA Hear t® 
Office by 30 September 2020.
The scholarship is for the value of up to R25 000.00 for international meetings and R10 000.00 for local meetings.
This scholarship is available to all members residing in South Africa. It is primarily intended to assist junior colleagues 
to ensure continued par ticipation in local or international scientific meetings or workshops.
requiremeNts
■ Applicants must be fully paid-up members for at least 1 year.
reCommeNdAtioNs
■  Early and mid-career applicants (<5 years post-qualification as specialist and/or <5 years post-PhD qualification).
■  Acceptance of an abstract/poster presentation at the scientific meeting to be attended.
CoNditioNs
■  Awards will not be made for conferences or workshops retrospective to the application submission deadline. 
If the conference is taking place within six (6) weeks following the submission deadline, please indicate this in 
the appropriate place on the application form.
■  It is not a requirement for the abstract to be accepted by the conference travel application closing date. 
Should the acceptance of the paper, including proof of registration not be available at the time of submission 
of the application, then a provisional award may be made pending receipt of the acceptance of the paper.
■  Please ensure that applications are made as well in advance as possible (preferably at least 6 months prior 
to the conference date).
■  Applicants may only submit 1 application every second year. The scholarship is for the value of up to 
R25 000.00 for international meetings and R10 000.00 for local meetings.
■  Awards are only made in the event that a paper or a poster is being presented or in the event of a workshop 
attendance, if the reviewers deem the workshop attendance to be of high impact and consequently of benefit 
to the SA Hear t® community.
■  The applicant must ensure that the application is fully completed including the requirements as detailed in the 
checklist section. Applicants are asked to be concise and to only include applicable and relevant information.
■  Awards are granted for 1 specific conference. Should that specific conference be cancelled or the full amount 
allocated not utilised for any reason, then the funds must rever t to SA Hear t®; and
■  A written repor t on the relevant congress attended will need to be submitted by the successful applicant 
within 6 weeks of attending the congress. The congress repor t will be published in the South African Hear t 
Association Newsletter.
suBmissioN requiremeNts
■   For more information and application forms, please visit https://www.sahear t.org/cms-home/category/39.
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accepted by the relevant congress organising committee, 
the applicant will forfeit his or her sponsorship towards 
the congress. (Application can however be made well in 
advance of the relevant congress but will only be awarded 
on acceptance of the abstract.) A written report on the 
relevant congress attended will need to be submitted by 
the successful applicant within 6 weeks of attending the 
congress. The congress report will be published in the 
South African Heart Association Newsletter.
Applications should be sent to Dr Alfonso Pecoraro, 
President of the Western Cape branch of the South 
African Heart Association, Division of Cardiology, Tyger-
berg Hospital, Francie van Zijl Drive, Tygerberg 7505; or 
alternatively email: pecoraro@sun.ac.za.
Previous recipients of this prestigious award include 
Sandrine Lecour, Roisin Kelle, Liesl Zühlke and Prof Hans 
Strijdom.  
Applications close on 31 January 2021.
Louis VoGeLPoeL trAVeLLiNG sChoLArshiP
A gifted and 
enthusiastic 
teacher, he was 
instrumental in  
the training of 
generations of 
undergraduates.
Applications are invited for the annual Louis Vogelpoel Travelling Scholarship for 2020. An amount of up to R20 000 towards the 
travel and accommodation costs of a local or interna- 
tional congress will be offered annually by the Western 
Cape branch of the South African Heart Association in 
memory of one of South Africa’s outstanding cardiologists, 
Dr Louis Vogelpoel. 
Louis Vogelpoel was a pioneer of cardiology in South 
Africa who died in April 2005. He was one of the 
founding members of the Cardiac Clinic at Groote Schuur 
Hospital and the University of Cape Town. He had an 
exceptional career of more than 5 decades as a dis-
tinguished general physician, cardiologist and horticultural 
scientist. Dr Vogelpoel’s commitment to patient-care, 
teaching and personal education is remembered by his 
many students, colleagues and patients. Medical students, 
house officers, registrars and consultants benefited from 
exposure to his unique blend of clinical expertise, extensive 
knowledge, enthusiasm and gracious style. 
A gifted and enthusiastic teacher, he was instrumental in 
the training of generations of undergraduates by regular 
bedside tutorials. He served as an outstanding role model 
for postgraduates and many who have achieved pro-
minence nationally and internationally acknowledged his 
contribution to the development of their careers. 
All applications for the scholarship will be reviewed by the 
executive committee of the Western Cape branch of the 
South African Heart Association. Preference will be given 
to practitioners or researchers in the field of cardiovascular 
medicine who are members of the South African Heart 
Association and are resident in the Western Cape.
Applications should include: (1) A brief synopsis of the 
work the applicant wishes to present at the congress; and 
(2) A brief letter of what the applicant hopes to gain by 
attending the relevant congress. The applicant should sub-
mit an abstract for presentation at the relevant national or 
international meeting. Should such an abstract not be 
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hefssA trAVeL sChoLArshiP 
iNtroduCtioN
The Executive Committee of the Heart Failure Society of South Africa (HeFSSA) has established 
the HeFSSA Travel Scholarship. As part of its contribution towards optimising patient care and 
to enhance and promote local heart failure expertise, HeFSSA supports such an award in 
South Africa. We hope that the information gained during this event and the possibility of 
sharing your experience and opening a dialogue with other specialists, will broaden your 
knowledge regarding new products and therapies in your field of expertise. We also hope that 
this experience will help you to develop educational programmes at your medical institution 
and to share the acquired knowledge with your colleagues actively.
VALue
Two travel grants are available annually. Each grant is valued at a maximum of R35 000 which 
may be used towards economy airfare, registration and accommodation. 
eLiGiBiLitY
Candidates may be a medical practitioner in the public or private sector (i.e. a cardiologist, 
physician, internal medicine practitioner, Cardiology Fellow or similar) or researcher (basic 
scientist in heart failure). Applicants must be paid-up members of the SA Heart® Association 
and HeFSSA. The programme/course/conference needs to be internationally or locally 
accredited and focussed on promoting your knowledge of heart failure.
APPLiCAtioN
Applications can be submitted to HeFSSA at info@hefssa.org. Please include your contact 
details and hospital affiliation, qualification, private and or public practice, and if you are an 
RSA citizen (or permanent resident). Provide a motivation as to why the specific programme 
or course has been selected and include the programme of the conference (or URL). The 
HeFSSA office will confirm receipt by return email. Application for this award does not 
guarantee that the applicant will receive the award. No correspondence will be entertained 
after a decision is made. The applicant will be notified of the outcome of the applications 
within 4 weeks of receipt.
ProCess ANd terms
The grant recipient needs to book, pay and then claim back (with proof documentation) from 
HeFSSA. Refund will be actioned within 24 hours. Twenty percent of the grant amount will be 
retained by HeFSSA (R7 000) and will be paid to the recipient as soon as CPD certificate and 
a meeting report is received.
Within one month of returning from the conference, the recipient must submit a substantial 
evaluation/review of the course content. This should reflect on key lectures and late-breaking 
trials as well as other sessions attended, which will impact on the practice going forward. Include 
some photographs. The purpose of this report is to share knowledge gained that could impact 
on colleagues’ practices. The report should be included in the SA Heart® newsletter and/or the 
HeFSSA newsletter. 
HeFSSA strongly recommends that the recipient create the opportunity to give feedback 
through a lecture delivered at appropriate educational forums (please confirm with HeFSSA 
when these take place).
Should the recipient not attend the conference, HeFSSA reserves the right to request repay-
ment of any monies paid.
“eNhANCiNG heArt fAiLure mANAGemeNt iN south AfriCA”
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the south AfriCAN heArt AssoCiAtioN
reseArCh sChoLArshiP
This scholarship is available to full and associate members of the SA Hear t® Association living in South Africa. 
It is primarily intended to assist colleagues involved in much-needed research to enhance their research 
programmes.
requiremeNts
■	  Applicants need to be fully paid up members/associate members in good standing for at least one year.
■  Applications must include:
	 ■	The applicant’s abbreviated CV
	 ■	A breakdown of the anticipated expenses
	 ■	Ethics approval
	 ■	Full details of the research
	 ■	The completed application form  - please request a fillable MS Word document from erika@sahear t.org
	 ■	Contact details of Head of Depar tment or supervisor/mentor
reCommeNdAtioNs
■   Preference will be given to early and mid-career applicants (<5 years post-qualification as specialist and/or 
<5 years post-PhD qualification).
CoNditioNs
■   Applicants may only submit 1 application every second year. Preference is given to those who have not had 
previous scholarships awarded.
■   Awards are granted for one specific research project. Should that specific project be cancelled or the full 
amount allocated not be utilised for any reason, then the funds must rever t to SA Hear t®.
APPLiCAtioNs must Be emAiLed to:
erika@sahear t.org
the seLeCtioN PANeL wiLL reView APPLiCAtioNs ANNuALLY ANd the CLosiNG 
dAte is 30 sePtemBer 2020.
One scholarship to a maximum amount of R65 000 will be awarded annually.
sA heart® commits to inclusive excellence by advancing equity and diversity.
we particularly encourage applications from members of historically under 
represented racial/ethnic groups, women and individuals with disabilities.
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Notes
